HomeClinical TopicsCardio-PulmonaryFDA approves Ferriprox for thalassemia patients with iron overload from blood transfusions

FDA approves Ferriprox for thalassemia patients with iron overload from blood transfusions

The U.S. Food and Drug Administration has Ferriprox (deferiprone) for the treatment of iron overload caused by blood transfusions in patients with thalassemia. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content